Epidemiology of chronic kidney disease in young patients in developing countries

Allieu Tommy1, Jonathan Soldera2,3

  • 1Department of Acute Medicine, University of South Wales (in association with Learna Ltd.), Cardiff CF37 1DL, United Kingdom.

Insights

Chronic kidney disease (CKD) is common in young people in low- and middle-income countries (LMICs). Prevalence varies significantly by study setting and region, highlighting the need for targeted surveillance.

Area of Science:

  • Global Health
  • Nephrology
  • Epidemiology

Background:

  • Chronic kidney disease (CKD) is a significant health issue in young populations within low- and middle-income countries (LMICs).
  • Epidemiological data on CKD in this demographic in LMICs are scarce and fragmented.
  • LMICs are defined by the World Bank with a gross national income per capita between $1136 and $13845 (2024).

Purpose of the Study:

  • To determine the prevalence of CKD in individuals aged 25 years and younger in LMICs.
  • To investigate the factors contributing to variability in CKD prevalence estimates across studies.

Main Methods:

  • A systematic review and meta-analysis were conducted following PRISMA 2020 guidelines.
  • Searches were performed in PubMed, EMBASE, Cochrane Library, and Google Scholar for relevant studies.
  • Pooled prevalence was calculated using a random intercept logistic regression model, with heterogeneity assessed using standard statistics and meta-regression.

Main Results:

  • Nineteen studies from 17 countries, including 339,940 participants, were analyzed.
  • The overall pooled CKD prevalence was 11.7%, with substantial heterogeneity (I² = 99.9%).
  • Study setting and geographic region significantly contributed to between-study variance, explaining 61.4% combined. Prevalence estimates were lower in community-based studies compared to registries.

Conclusions:

  • CKD is prevalent and highly variable among young individuals in LMICs.
  • Differences in study settings and geographic locations are primary drivers of this variability.
  • Targeted early detection and surveillance strategies for CKD in young populations in LMICs are essential.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...